Please visit answersincme.com/860/240201321-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Neda Amiri, MD, MHSc, FRCPC, ABIM; Dharini Mahendira, MD, FRCPC, MScCH and Eleftherios Soleas, PhD. In this activity, experts in rheumatology discuss evidence-based strategies to facilitate the selection and optimization of biologic therapies in women with inflammatory arthritis who are of childbearing potential. Upon completion of this activity, participants should be better able to: Describe how patient-specific factors, including fertility status, pregnancy, and lactation, inform personalized biological therapy selection in inflammatory arthritis; Evaluate the efficacy and safety profiles of approved biologics in women of childbearing potential across inflammatory arthritis indications; and Apply strategies to optimize management decisions in reproductive-age women with inflammatory arthritis.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Early Defense: Answering Key Questions About the Science and Strategy of RSV Prevention in Infants
Test, Treat, Repeat: Closing Persistent Gaps in HCV Care
When Form Maximizes Function: Examining the Role of Subcutaneous Immune Checkpoint Inhibitors in Oncology Practice
Precision Use of Biologic Therapies in Eosinophilic Lung Disease: Case-Based Strategies to Optimize Treatment Selection and Reduce Steroid Burden
Free AI-powered recaps of CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.